FDA: Lots of blood pressure medication recalled in the United States after dissolving failure

More than 11,000 bottles of a common blood pressure control medication have been withdrawn from the market. The recall of chlorthalidone was announced by the United States Food and Drug Administration (FDA), involving a large number of packages that were in circulation.
The company Inventia Healthcare Limited was responsible for manufacturing the medicine, which requires a medical prescription for its acquisition. The measure, implemented on June 5, is due to “flaws in the dissolution specifications”, which indicates that the tablets may not release the active ingredient as expected, directly compromising their effectiveness in treating pressure.
Accurate identification of medication with dissolution problems
Consumers and healthcare professionals can check the details of the affected product to identify if they have any of the recalled vials:
- Product Description:Chlorthalidone Tablets, USP, 25 mg
- Pack of 100 tablets:With NDC: 64980-599-01 and batch code: RISA24001
- Pack of 1,000 tablets:With NDC: 64980-599-10 and batch code: ISB24002
- Expiration date:April 2027
- Total volume affected:11,460 bottles
Guidance for patients with recalled medication
To date, the FDA has not specified the level of risk associated with this failure nor released detailed instructions for the general public. The primary recommendation is that individuals using the medication check the batch and consult their doctor or pharmacist.
It is important not to stop using any medication without professional guidance. According to Jennifer Young, pharmacist and medication safety specialist at the Institute for Safe Medication Practices, abruptly discontinuing a medication can, in some situations, present greater risks than the reason for the withdrawal itself.
The specialist reinforces that, even in the face of warnings about medication safety, immediate communication with a healthcare professional is essential. This measure ensures that any change in the medication routine is made in a safe and personalized way, avoiding unwanted consequences.






